Treatment disparities in muscle-invasive bladder cancer: Evidence from a large statewide cancer registry-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment disparities in muscle-invasive bladder cancer: Evidence from a large statewide cancer registry

Published:2022-04 Issue:4 Volume:40 Page:164.e17-164.e23
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Shah Anup A.,Sun ZhaoJun^ORCID,Eom Kirsten Y.^ORCID,Grajales Valentina,Pekala Kelly R.^ORCID,Davies Benjamin J.,Jacobs Bruce L.,Sabik Lindsay M.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference27 articles.

1. Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a surveillance, epidemiology, and end results-medicare analysis;Gore;Cancer,2009

2. An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma;Sanchez-Ortiz;J Urol,2003

3. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer;Grossman;N Engl J Med,2003

4. Guideline: treatment of non-metastatic muscle-invasive bladder cancer;J Urol,2017

5. Influence of post-cystectomy complications on cost and subsequent outcome;Konety;J Urol,2007

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Social Vulnerability and Receipt of Neoadjuvant Chemotherapy in Patients Undergoing Radical Cystectomy for Bladder Cancer;Urology;2024-09

2. Impact of rural location on receipt of standard of care treatment and survival for locally advanced bladder cancer in Louisiana;Cancer Medicine;2024-06

3. Income Disparities in Survival and Receipt of Neoadjuvant Chemotherapy and Pelvic Lymph Node Dissection for Muscle-Invasive Bladder Cancer;Current Oncology;2024-05-02

4. Implications of the interaction between travel burden and area deprivation for patients with pancreatic cancer;The American Journal of Surgery;2023-10

5. Comparison of Primary Payer in Cancer Registry and Discharge Data;The American Journal of Managed Care;2023-09-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3